#497

I’m no financial advisor but Eli Lilly trying to class Reta as a…

I’m no financial advisor but Eli Lilly trying to class Reta as a biologic instead of a peptide to charge more feels dumb. Reta is better than Tirz but not good enough for the average consumer to justify spending hundreds more per month on it. I don’t think they’ll be able to make it as expensive as they want to

Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →

Stay informed

New confessions and analysis, weekly.

Have your own story?

Anonymous. We publish roughly 1 in 10.

Submit anonymously →

Published August 20, 2026